Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis

ABSTRACT: Patients with rheumatoid arthritis (RA) and autoantibodies, such as rheumatoid factor and those against cyclic citrullinated peptides, are designated as seropositive and have a more severe disease with worse prognosis than seronegative RA patients. Understanding the factors that participat...

Full description

Autores:
Burbano Arciniegas, Catalina
Rojas López, Mauricio
Muñoz Vahos, Carlos
Vanegas García, Adriana
Correa Londoño, Luis Alfonso
Vásquez Duque, Gloria María
Castaño Monsalve, Diana María
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/36541
Acceso en línea:
https://hdl.handle.net/10495/36541
Palabra clave:
Artritis Reumatoide
Arthritis, Rheumatoid
Autoanticuerpos
Autoantibodies
Citocinas
Cytokines
Vesículas Extracelulares
Extracellular Vesicles
Monocitos
Monocytes
Péptidos Cíclicos
Peptides, Cyclic
Factor Reumatoide
Rheumatoid Factor
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
Description
Summary:ABSTRACT: Patients with rheumatoid arthritis (RA) and autoantibodies, such as rheumatoid factor and those against cyclic citrullinated peptides, are designated as seropositive and have a more severe disease with worse prognosis than seronegative RA patients. Understanding the factors that participate in systemic inflammation, in addition to articular commitment, would allow better treatment approaches for prevention of RA comorbidities and disease reactivation. We evaluated whether monocyte subsets and extracellular vesicles (EVs) could contribute to this phenomenon. Seropositive patients had higher levels of proinflammatory cytokines than those of seronegative patients and healthy controls (HCs); however, this systemic inflammatory profile was unrelated to disease activity. High frequencies of circulating EVs positive for IgG, IgM, CD41a, and citrulline, together with altered counts and receptor expression of intermediate monocytes, were associated with systemic inflammation in seropositive patients; these alterations were not observed in seronegative patients, which seem to be more similar to HCs. Additionally, the EVs from seropositive patients were able to activate mononuclear phagocytes in vitro, and induced proinflammatory cytokines that were comparable to the inflammatory response observed at the systemic level in seropositive RA patients; therefore, all of these factors may contribute to the greater disease severity that has been described in these patients.